Key statistics
As of last trade, Pacira Biosciences Inc (82P:STU) traded at 18.30, 18.06% above the 52 week low of 15.50 set on Jan 19, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 17.70 |
|---|---|
| High | 18.40 |
| Low | 17.10 |
| Bid | 18.30 |
| Offer | 18.40 |
| Previous close | 17.80 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 41.10m |
| Free float | 40.30m |
| P/E (TTM) | 46.59 |
| Market cap | 893.10m USD |
| EPS (TTM) | 0.4664 USD |
Data delayed at least 15 minutes, as of Feb 11 2026.
More ▼
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors
- Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets
- Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues
- Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences
- Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety and Significant Improvements in Pain With iovera° Compared to Radiofrequency Ablation in Chronic Low Back Pain
- Pacira BioSciences Files EXPAREL® Patent Infringement Lawsuits Against The WhiteOak Group and Qilu Pharmaceutical
- Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
More ▼
